Innovative Medical Management Co Ltd - Asset Resilience Ratio
Innovative Medical Management Co Ltd (002173) has an Asset Resilience Ratio of 4.15% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Innovative Medical Management Co Ltd (002173) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2025)
This chart shows how Innovative Medical Management Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Innovative Medical Management Co Ltd total assets.
Liquid Assets Composition Over Time
This chart breaks down Innovative Medical Management Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 002173 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥85.03 Million | 4.15% |
| Total Liquid Assets | CN¥85.03 Million | 4.15% |
Asset Resilience Insights
- Limited Liquidity: Innovative Medical Management Co Ltd maintains only 4.15% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Innovative Medical Management Co Ltd Industry Peers by Asset Resilience Ratio
Compare Innovative Medical Management Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
PRADA S.P.A.UNS.ADR/2 EO1
F:PRP0 |
Luxury Goods | 0.00% |
|
Shanghai Yuyuan Tourist Mart Co Ltd
SHG:600655 |
Luxury Goods | 2.63% |
|
Lao Feng Xiang Co Ltd B
SHG:900905 |
Luxury Goods | 0.80% |
|
Radhika Jeweltech Limited
NSE:RADHIKAJWE |
Luxury Goods | 0.02% |
|
Jubilee Enterprise Public Company Limited
BK:JUBILE |
Luxury Goods | 48.37% |
|
Silgo Retail Limited
NSE:SILGO |
Luxury Goods | 1.61% |
|
Moksh Ornaments Limited
NSE:MOKSH |
Luxury Goods | 5.11% |
|
Michael Hill International Ltd
AU:MHJ |
Luxury Goods | 16.65% |
Annual Asset Resilience Ratio for Innovative Medical Management Co Ltd (2017–2025)
The table below shows the annual Asset Resilience Ratio data for Innovative Medical Management Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 3.86% | CN¥84.01 Million ≈ $12.29 Million |
CN¥2.18 Billion ≈ $318.87 Million |
-9.20pp |
| 2024-12-31 | 13.06% | CN¥287.80 Million ≈ $42.11 Million |
CN¥2.20 Billion ≈ $322.51 Million |
+12.18pp |
| 2023-12-31 | 0.88% | CN¥20.08 Million ≈ $2.94 Million |
CN¥2.28 Billion ≈ $333.85 Million |
-21.58pp |
| 2021-12-31 | 22.46% | CN¥574.04 Million ≈ $84.00 Million |
CN¥2.56 Billion ≈ $374.05 Million |
+0.29pp |
| 2020-12-31 | 22.17% | CN¥593.52 Million ≈ $86.85 Million |
CN¥2.68 Billion ≈ $391.81 Million |
+20.10pp |
| 2019-12-31 | 2.07% | CN¥61.44 Million ≈ $8.99 Million |
CN¥2.97 Billion ≈ $434.32 Million |
+1.00pp |
| 2018-12-31 | 1.07% | CN¥45.46 Million ≈ $6.65 Million |
CN¥4.27 Billion ≈ $624.14 Million |
-15.71pp |
| 2017-12-31 | 16.77% | CN¥780.00 Million ≈ $114.14 Million |
CN¥4.65 Billion ≈ $680.47 Million |
-- |
About Innovative Medical Management Co Ltd
Innovative Medical Management Co.,Ltd. engages in the medical services business in China. The company owns and operates Jianhua Hospital, Kanghua Hospital, Futian Hospital, and Mingzhu Hospital. It also offers outpatient, inpatient, rehabilitation services, and medical examination services. In addition, it offers supply chain management and procurement of pharmaceuticals, medical consumables, and… Read more